We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.37B
AUM Growth
+$142M
Cap. Flow
+$10.8M
Cap. Flow %
0.79%
Top 10 Hldgs %
29.55%
Holding
194
New
9
Increased
52
Reduced
83
Closed
4

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$8.55M
2
PYPL icon
PayPal
PYPL
+$1.23M
3
SNY icon
Sanofi
SNY
+$1.23M
4
NVS icon
Novartis
NVS
+$1.08M
5
PPLI
People Inc
PPLI
+$918K

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$1.59M
2
BC icon
Brunswick
BC
+$1.26M
3
MSFT icon
Microsoft
MSFT
+$1.23M
4
DVN icon
Devon Energy
DVN
+$880K
5
CTSH icon
Cognizant
CTSH
+$748K

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 17.1%
3 Industrials 13.26%
4 Financials 11.2%
5 Consumer Staples 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
$1.95M 0.14%
15,146
+394
+3% +$50.8K
HON icon
77
Honeywell
HON
$78.3B
$1.83M 0.13%
9,047
-53
-0.6% -$10.1K
GOOG icon
78
Alphabet (Google) Class C
GOOG
$4.07T
$1.79M 0.13%
20,180
-340
-2% -$32.4K
NBIX icon
79
Neurocrine Biosciences
NBIX
$18.4B
$1.78M 0.13%
14,904
+625
+4% +$73.2K
GOOGL icon
80
Alphabet (Google) Class A
GOOGL
$4.08T
$1.76M 0.13%
19,930
-430
-2% -$40.9K
HD icon
81
Home Depot
HD
$343B
$1.71M 0.13%
5,414
-10
-0.2% -$3.05K
SPY icon
82
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.68M 0.12%
4,393
-87
-2% -$33.4K
CL icon
83
Colgate-Palmolive
CL
$74.2B
$1.64M 0.12%
20,757
-859
-4% -$64.4K
ADP icon
84
Automatic Data Processing
ADP
$106B
$1.6M 0.12%
6,706
-175
-3% -$43K
BMRN icon
85
BioMarin Pharmaceuticals
BMRN
$12B
$1.59M 0.12%
15,410
+1,037
+7% +$97.4K
ABT icon
86
Abbott
ABT
$187B
$1.56M 0.11%
14,250
-28
-0.2% -$2.9K
VEU icon
87
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$1.48M 0.11%
29,426
+13,696
+87% +$665K
MMM icon
88
3M
MMM
$94.1B
$1.38M 0.1%
13,730
-172
-1% -$17.5K
INCY icon
89
Incyte
INCY
$26B
$1.37M 0.1%
17,040
+1,125
+7% +$86.1K
BMY icon
90
Bristol-Myers Squibb
BMY
$130B
$1.35M 0.1%
18,761
-251
-1% -$18.9K
EMR icon
91
Emerson Electric
EMR
$85B
$1.25M 0.09%
13,064
FAST icon
92
Fastenal
FAST
$55.2B
$1.25M 0.09%
52,720
-4,172
-7% -$102K
CTRA
93
DELISTED
Coterra Energy
CTRA
$1.23M 0.09%
50,104
LLY icon
94
Eli Lilly
LLY
$1.09T
$1.21M 0.09%
3,301
+380
+13% +$135K
IONS icon
95
Ionis Pharmaceuticals
IONS
$9.14B
$1.19M 0.09%
31,474
+2,403
+8% +$101K
ISRG icon
96
Intuitive Surgical
ISRG
$130B
$1.13M 0.08%
4,261
-50
-1% -$12.2K
IVV icon
97
iShares Core S&P 500 ETF
IVV
$871B
$1.12M 0.08%
2,914
-58
-2% -$22.4K
VV icon
98
Vanguard Large-Cap ETF
VV
$52B
$1.07M 0.08%
6,148
-60
-1% -$10.5K
UNP icon
99
Union Pacific
UNP
$175B
$1.07M 0.08%
5,157
-100
-2% -$20.5K
EBAY icon
100
eBay
EBAY
$52.1B
$1.04M 0.08%
24,989
-500
-2% -$20.7K

Similar funds

Grandfield & Dodd's Q4 2022 Portfolio in Review

As of Q4 2022, Grandfield & Dodd held 194 positions worth $1.37B, up 12% from $1.22B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q4 2022 filing shows 9 new, 52 increased, 83 reduced and 4 closed positions. Its largest new stake was Duke Energy: 2,659 shares worth $274K. The largest sale was Synopsys, an estimated $1.59M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q4 2022 buy was Duke Energy: 2,659 shares worth $274K.
  • Grandfield & Dodd added most to GE Aerospace in Q4 2022, an estimated $8.55M increase.
  • Grandfield & Dodd's biggest Q4 2022 reduction was Synopsys, cutting an estimated $1.59M.
  • Grandfield & Dodd fully exited CarMax in Q4 2022, selling an estimated $240K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.37B portfolio in Q4 2022.
  • Grandfield & Dodd opened 9 new positions and closed 4 in Q4 2022.
  • Grandfield & Dodd's portfolio value rose 12% quarter-over-quarter to $1.37B.

Based on Grandfield & Dodd's 13F filing for Q4 2022, filed 20 Jan 2023.